Sotac Pharmaceuticals Ltd.

Financial

	Sotac Pharmaceutical	Parnax Lab	Tyche Inds
Operational Metrics
Financials
5 yr Average ROE	-4.85 %	6.88 %	14.86 %
5yr average Equity Multiplier	7.05	2.94	1.18
5yr Average Asset Turnover Ratio	1.3	0.99	0.6
5yr Avg Net Profit Margin	1.45 %	2.37 %	20.15 %
Price to Book	0.0	1.73	1.04
P/E	18.01	12.47	11.41
5yr Avg Cash Conversion Cycle	3.3 Days	42.8 Days	86.71 Days
Inventory Days	36.47 Days	42.33 Days	61.45 Days
Days Receivable	72.11 Days	58.46 Days	108.17 Days
Days Payable	136.32 Days	69.32 Days	93.08 Days
5yr Average Interest Coverage Ratio	3.3	2.32	2385.83
5yr Avg ROCE	19.17 %	15.17 %	19.65 %
5yr Avg Operating Profit Margin	7.12 %	11.62 %	23.57 %
5 yr average Debt to Equity	2.81	1.28	0.0
5yr CAGR Net Profit	116.49 %	n/a	-6.96 %
5yr Average Return on Assets	1.93 %	2.67 %	12.43 %
Shareholdings
Promoter Holding	72.85 %	72.3 %	61.97 %
Share Pledged by Promoters	0.0	9.41 %	0.0
Change in Promoter Holding (3 Yrs)	0.0	4.72 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Sotac Pharmaceutical	Parnax Lab	Tyche Inds
Product Wise Break-Up	Product Wise Break-Up Tablet 94.47 Capsules 4.83 Liquid 0.57 Ointment 0.13 Manufacture of bulk drugs intermediates 0	Product Wise Break-Up Tablet 0 Manufacture of bulk drugs intermediates 0 Capsules 0 Liquid 0 Ointment 0 Others 100	Product Wise Break-Up Tablet 0 Bulk Chemicals 100.0 Capsules 0 Liquid 0 Ointment 0
Location Wise Break-Up	Location Wise Break-Up Gujarat 94.97 Maharashtra 2.98 Karnataka 1.32 Assam 0.14 Madhya Pradesh 0.09 Andhra Pradesh 0.06 International 0 Domestic 0 Others 0.44	-	Location Wise Break-Up Assam 0 International 67.08 Domestic 32.92 Maharashtra 0 Madhya Pradesh 0 Andhra Pradesh 0 Karnataka 0 Gujarat 0